Prosoria
Commercial- Indications
- Psoriasis
Company intelligence / Profile preview
Nuvothera has commercialized two main product lines—a super-micronized turmeric curcumin supplement for joint health and inflammation, and Prosoria, an over-the-counter topical system for psoriasis. The company claims improved bioavailability for its turmeric product and clinical-strength efficacy for its skin treatments. No formal clinical trial data or regulatory drug approvals are reported; all claims are based on consumer use and in vitro testing.
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nuvothera.